183 related articles for article (PubMed ID: 15519999)
1. EVI1 abrogates interferon-alpha response by selectively blocking PML induction.
Buonamici S; Li D; Mikhail FM; Sassano A; Platanias LC; Colamonici O; Anastasi J; Nucifora G
J Biol Chem; 2005 Jan; 280(1):428-36. PubMed ID: 15519999
[TBL] [Abstract][Full Text] [Related]
2. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator.
Soderholm J; Kobayashi H; Mathieu C; Rowley JD; Nucifora G
Leukemia; 1997 Mar; 11(3):352-8. PubMed ID: 9067573
[TBL] [Abstract][Full Text] [Related]
3. The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells.
Maicas M; Vázquez I; Alis R; Marcotegui N; Urquiza L; Cortés-Lavaud X; Cristóbal I; García-Sánchez MA; Odero MD
Biochim Biophys Acta Gene Regul Mech; 2017 Jun; 1860(6):721-729. PubMed ID: 28391050
[TBL] [Abstract][Full Text] [Related]
4. EVI1 Interferes with Myeloid Maturation via Transcriptional Repression of Cebpa, via Binding to Two Far Downstream Regulatory Elements.
Wilson M; Tsakraklides V; Tran M; Xiao YY; Zhang Y; Perkins AS
J Biol Chem; 2016 Jun; 291(26):13591-607. PubMed ID: 27129260
[TBL] [Abstract][Full Text] [Related]
5. MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1.
Sood R; Talwar-Trikha A; Chakrabarti SR; Nucifora G
Leukemia; 1999 Mar; 13(3):348-57. PubMed ID: 10086725
[TBL] [Abstract][Full Text] [Related]
6. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract][Full Text] [Related]
7. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
[TBL] [Abstract][Full Text] [Related]
8. Physical and functional link of the leukemia-associated factors AML1 and PML.
Nguyen LA; Pandolfi PP; Aikawa Y; Tagata Y; Ohki M; Kitabayashi I
Blood; 2005 Jan; 105(1):292-300. PubMed ID: 15331439
[TBL] [Abstract][Full Text] [Related]
9. Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles.
Chakraborty S; Senyuk V; Sitailo S; Chi Y; Nucifora G
J Biol Chem; 2001 Nov; 276(48):44936-43. PubMed ID: 11568182
[TBL] [Abstract][Full Text] [Related]
10. The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid.
Steinmetz B; Hackl H; Slabáková E; Schwarzinger I; Smějová M; Spittler A; Arbesu I; Shehata M; Souček K; Wieser R
Cell Cycle; 2014; 13(18):2931-43. PubMed ID: 25486480
[TBL] [Abstract][Full Text] [Related]
11. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.
Fears S; Mathieu C; Zeleznik-Le N; Huang S; Rowley JD; Nucifora G
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1642-7. PubMed ID: 8643684
[TBL] [Abstract][Full Text] [Related]
12. The role of EVI1 in normal and leukemic cells.
Buonamici S; Chakraborty S; Senyuk V; Nucifora G
Blood Cells Mol Dis; 2003; 31(2):206-12. PubMed ID: 12972028
[TBL] [Abstract][Full Text] [Related]
13. Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia.
Glass C; Wuertzer C; Cui X; Bi Y; Davuluri R; Xiao YY; Wilson M; Owens K; Zhang Y; Perkins A
PLoS One; 2013; 8(6):e67134. PubMed ID: 23826213
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic PML function in TGF-beta signalling.
Lin HK; Bergmann S; Pandolfi PP
Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
[TBL] [Abstract][Full Text] [Related]
15. Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defects.
Bard-Chapeau EA; Szumska D; Jacob B; Chua BQ; Chatterjee GC; Zhang Y; Ward JM; Urun F; Kinameri E; Vincent SD; Ahmed S; Bhattacharya S; Osato M; Perkins AS; Moore AW; Jenkins NA; Copeland NG
PLoS One; 2014; 9(2):e89397. PubMed ID: 24586749
[TBL] [Abstract][Full Text] [Related]
16. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
Sancéau J; Hiscott J; Delattre O; Wietzerbin J
Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
[TBL] [Abstract][Full Text] [Related]
17. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
Chen Y; Wright J; Meng X; Leppard KN
Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
[TBL] [Abstract][Full Text] [Related]
18. Evi1 forms a bridge between the epigenetic machinery and signaling pathways.
Yoshimi A; Kurokawa M
Oncotarget; 2011 Jul; 2(7):575-86. PubMed ID: 21795762
[TBL] [Abstract][Full Text] [Related]
19. Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis.
Jin G; Yamazaki Y; Takuwa M; Takahara T; Kaneko K; Kuwata T; Miyata S; Nakamura T
Blood; 2007 May; 109(9):3998-4005. PubMed ID: 17227832
[TBL] [Abstract][Full Text] [Related]
20. PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction.
Crowder C; Dahle Ø; Davis RE; Gabrielsen OS; Rudikoff S
Blood; 2005 Feb; 105(3):1280-7. PubMed ID: 15459016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
